Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

被引：13
|
作者：
Watanabe, Ryu [1 ]
Ishii, Tomonori [1 ]
Araki, Kyoko [1 ]
Ishizuka, Mariko [1 ]
Kamogawa, Yukiko [1 ]
Fujita, Yoko [1 ]
Shirota, Yuko [1 ]
Fujii, Hiroshi [1 ]
Harigae, Hideo [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan
来源：
MODERN RHEUMATOLOGY | 2016年 / 26卷 / 03期
关键词：
Clinically amyopathic dermatomyositis; Interstitial lung disease; Multi-target therapy; Rituximab; ANTIBODY;
D O I：
10.3109/14397595.2015.1012797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [41] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [42] ANTI-MDA5 (+) CLINICALLY AMYOPATHIC DERMATOMYOSITIS-ASSOCIATED RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: ROLE OF HEMOPERFUSION WITH POLYMYXIN
    Selva-O'callaghan, A.
    Vizcaino, C.
    Ruiz-Rodriguez, J. C.
    Trallero-Araguas, E.
    Ramos, N.
    Berastegui, C.
    Gil Vila, A.
    Martinez, M. A.
    Solanich, X.
    Ferrer, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1095 - 1095
  • [43] A RARE CASE OF RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN A PATIENT WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS WITH ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED GENE 5 ANTIBODIES
    Mahajan, Pranav
    Upadhyay, Riddhi
    Aedma, Surya
    Khan, Muhammad Talha
    Thameem, Danish
    CHEST, 2020, 158 (04) : 1165A - 1166A
  • [44] A Case of Rapidly Progressing Interstitial Lung Disease in the Setting of Clinically Amyopathic Dermatomyositis Requiring an Urgent Bilateral Lung Transplantation
    Patel, S.
    Price, J. D.
    Pinkston, O.
    Ramirez, A. M.
    Fox, M.
    Suliman, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [45] TWO CASES OF RAPIDLY PROGRESSIVE INTERSTITIAL PNEUMONIA ASSOCIATED WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS SUCCESSFULLY TREATED WITH EARLY INTENSIVE THERAPY
    Yoshioka, Yasuko
    Sasaki, Shinichi
    Matsuno, Kei
    Ishimori, Ayako
    Nanjo, Yuta
    Makino, Humihiko
    Muraki, Keiko
    Tominaga, Shigeru
    Takahashi, Kazuhisa
    RESPIROLOGY, 2013, 18 : 140 - 140
  • [46] Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis in a Post-partum Woman
    Gu, Qiao
    Diao, MengYuan
    Hu, Wei
    Huang, Man
    Zhu, Ying
    FRONTIERS IN MEDICINE, 2021, 8
  • [47] Rapidly Progressive Interstitial Lung Disease in the Setting of Anti-Melanoma Differentiation-Associated Gene 5 Positive Clinically Amyopathic Dermatomyositis
    Winter, D. L.
    Perelas, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [48] A Fatal Case of Anti-MDA5 Antibody Positive Clinically Amyopathic Dermatomyositis (CADM) Associated with Rapidly Progressive Interstitial Lung Disease
    Mohammed, A.
    Torres, C.
    AlNabulsi, M.
    Smith, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] Rituximab for Rapidly Progressive MDA5 Dermatomyositis-Associated Interstitial Lung Disease
    Mak, J.
    Gandhi, R.
    Zaidan, M. F.
    Murthy, V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [50] Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan
    Tokunaga, Kenichiro
    Hagino, Noboru
    INTERNAL MEDICINE, 2017, 56 (11) : 1399 - 1403
12345